Grand River buys more land to expand its manufacturing footprint in Michigan

Pills Getty
Fill-finish CMO Grand River Aseptic Manufacturing announced plans to expand its production capacity. (Getty)

Grand River Aseptic Manufacturing, a Michigan-based fill-finish CMO, said it has acquired a 1.5-acre plot of land near its current manufacturing facility as part of a planned expansion of its production capacity.

The lot, which is about a quarter mile from the company’s facility in Grand Rapids, Michigan, will eventually complement Grand River’s existing 40,000-square-foot space, the company said. When completed, the site will house a new cleanroom space, including new isolator technology, and will provide high-speed, fully integrated manufacturing and packaging lines.

Financial terms of the purchase, which is expected to close in 90 days, were not disclosed.

“The substantial growth rate that we’ve experienced in the last several years has allowed us to match the needs of our clients and the industry,” Tom Ross, Grand River’s president and chief executive, said in a statement. “With that growing demand, we are excited to add more manufacturing capacity, while remaining a quality-focused organization.”

In 2014, the company added a 28,000-square-foot addition to its pharmaceutical fill/finish facility.

Read more on

Suggested Articles

As COVID-19 vaccines advance, the FDA held an expert hearing Thursday to talk safety, efficacy, distribution plans and vaccine confidence—plus more. 

Dr. Reddy’s Laboratories has shut 'key' plants worldwide and all data center services as a preventive measure after detecting a data breach.

Switzerland's Lonza will spend $93 million to expand its capsule manufacturing capacity by 30 billion doses per year.